Binding of external ligands onto an engineered virus capsid

Area of Science:

• Biotechnology
• Drug Delivery Systems
• Molecular Engineering

Background:

• Targeted delivery of therapeutic substances is crucial for novel drug development.
• Receptor-binding domains are essential for directing carriers to specific tissues.
• Polyomavirus-like particles offer a versatile model system for carrier development.

Purpose of the Study:

• To engineer polyomavirus-like particles for targeted therapeutic delivery.
• To investigate the functional integration of a WW domain into viral capsid proteins.
• To evaluate the binding characteristics of the modified virus-like particles.

Main Methods:

• Recombinant expression of polyomavirus-like particles.
• Insertion of a WW domain sequence into surface loops of the VP1 capsid protein.
• Analysis of ligand binding affinity and kinetics.

Main Results:

• The engineered WW domain retained selective binding to proline-rich ligands.
• The modified virus-like particles exhibited increased binding affinity compared to isolated WW domains.
• An accelerated association/dissociation equilibrium was observed, enabling short-term ligand coupling.

Conclusions:

• Virus-like particles can be effectively engineered for targeted drug delivery applications.
• WW domain integration provides a mechanism for controllable, short-term ligand attachment.
• This approach facilitates the development of advanced therapeutic delivery systems.